Management Protocol for Neonatal Seizures
Phenobarbital is the first-line treatment for neonatal seizures at a loading dose of 20 mg/kg IV, regardless of seizure etiology. 1, 2
Initial Assessment and Stabilization
- Assess circulation, airway, and breathing (CAB) and provide appropriate airway protection 3
- Administer high-flow oxygen to prevent hypoxia 3
- Check blood glucose level immediately to rule out hypoglycemia as a potential cause 3
- Initiate continuous EEG monitoring to confirm seizures and monitor response to treatment 1, 2
First-Line Treatment
- Administer phenobarbital 20 mg/kg IV loading dose 1, 2
- This dose typically achieves therapeutic plasma levels (15-30 μg/mL) within minutes of injection 4
- If seizures persist after 20 minutes, consider giving an additional 10 mg/kg dose of phenobarbital (maximum total loading dose: 40 mg/kg) 2
Second-Line Treatment (if seizures persist after phenobarbital)
- Options include (in order of preference):
- Levetiracetam 40-60 mg/kg IV (preferred in neonates with cardiac disorders) 1, 2
- Fosphenytoin/phenytoin 15-20 mg/kg IV (consider as first-line if channelopathy is suspected) 2, 5
- Midazolam 0.1-0.2 mg/kg IV bolus followed by continuous infusion (0.1-0.4 mg/kg/hour) 1, 2
- Lidocaine (if available) 2 mg/kg IV bolus followed by continuous infusion (4-6 mg/kg/hour) 1, 2
Third-Line Treatment (for refractory seizures)
- Consider continuous midazolam infusion with escalating doses 1
- For suspected vitamin B6-dependent epilepsy with seizures unresponsive to second-line ASMs, attempt a trial of pyridoxine 2
- Consider consultation with pediatric neurology for further management 2
Maintenance Therapy
- After seizure control is achieved, maintain phenobarbital at 3-4 mg/kg/day divided into 1-2 doses 4
- Due to long half-life (69-165 hours), monitor for drug accumulation; avoid exceeding 5 mg/kg/day 4
Duration of Treatment
- For acute symptomatic seizures without evidence of neonatal-onset epilepsy, discontinue antiseizure medications before discharge home 2
- Early discontinuation after 1-2 weeks is generally possible 4
- This recommendation applies regardless of MRI or EEG findings 2
Special Considerations
- Therapeutic hypothermia may reduce seizure burden in neonates with hypoxic-ischemic encephalopathy 2
- Treating electrographic-only seizures to achieve lower seizure burden may improve outcomes 2
- For neonates requiring muscle relaxants, administer phenobarbital before curare to enable more effective mechanical ventilation 4
Important Caveats
- Despite being the standard first-line treatment, phenobarbital controls seizures in fewer than half of neonates (43-45%) 5
- The severity of seizures is a stronger predictor of treatment success than the specific medication used 5
- Continuous EEG monitoring is essential to confirm seizure control, as clinical assessment alone is unreliable 1, 2
- Withdrawal-associated seizures in neonates are primarily myoclonic, respond to opiates, and carry no increased long-term risk of poor outcomes 6